Our Pricing

How to Purchase Saxenda UK: Clinical Guide and Pricing

Published on: June 03, 2026

When you purchase Saxenda UK through a registered online pharmacy, you're accessing a clinically proven GLP-1 receptor agonist containing liraglutide 6mg/ml, licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities. At Cured Pharmacy, Saxenda is available from £48.00 per pen following a free online consultation with our UK-registered prescribers, ensuring safe, legal access to this prescription-only medicine. Clinical trials demonstrate that Saxenda users lost an average of 8% of their initial body weight over 56 weeks when combined with a reduced-calorie diet and increased physical activity [1].

Understanding What You Purchase When Buying Saxenda UK

When you purchase Saxenda UK, you receive pre-filled injection pens containing liraglutide, a glucagon-like peptide-1 (GLP-1) analogue that mimics the action of the natural GLP-1 hormone. Each Saxenda pen delivers 6mg/ml liraglutide solution for subcutaneous injection, designed for daily self-administration at doses ranging from 0.6mg to the maintenance dose of 3.0mg [2]. The medication works by regulating appetite through hypothalamic pathways, slowing gastric emptying, and enhancing satiety signals, which collectively support sustainable weight reduction when combined with lifestyle modification.

Saxenda is manufactured by Novo Nordisk and holds full MHRA marketing authorisation in the UK for chronic weight management. The SCALE (Satiety and Clinical Adiposity – Liraglutide Evidence) trials established the efficacy profile, with the pivotal SCALE Obesity and Prediabetes trial showing 63.2% of participants achieved ≥5% weight loss versus 27.1% on placebo over 56 weeks [1]. As a prescription-only medicine (POM), every purchase of Saxenda UK requires clinical assessment by a registered prescriber to confirm suitability, contraindications, and individualised dosing protocols.

Clinical Eligibility to Purchase Saxenda UK Safely

To purchase Saxenda UK legally and safely, you must meet specific clinical criteria established by NICE and the MHRA. Saxenda is licensed for adults aged 18 years and over with an initial BMI of ≥30 kg/m² (obese) or ≥27 kg/m² to <30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea [3]. Our UK-registered prescribers assess your medical history, current medications, and weight management goals during the free online consultation to determine appropriateness.

Contraindications that preclude you from being able to purchase Saxenda UK include pregnancy or breastfeeding, personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), inflammatory bowel disease, diabetic gastroparesis, or severe renal or hepatic impairment [2]. The prescriber will also evaluate potential drug interactions, particularly with insulin or sulphonylureas where dose adjustments may be necessary to mitigate hypoglycaemia risk. At Cured Pharmacy, superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols to ensure compliance with GPhC and MHRA standards.

Pre-Treatment Health Screening

Before you purchase Saxenda UK, our clinical team reviews your cardiovascular risk profile, thyroid function history, and any prior episodes of pancreatitis. Liraglutide has been associated with transient increases in heart rate (average 2-3 bpm) and requires caution in patients with significant cardiovascular disease [3]. The consultation process at Cured Pharmacy takes under 3 minutes to complete online, with same-day prescriber review and next-day delivery available across the UK for approved patients.

Saxenda Dosing Protocol When You Purchase Saxenda UK

When you purchase Saxenda UK and begin treatment, you will follow a structured dose-escalation schedule designed to minimise gastrointestinal side effects while optimising therapeutic efficacy. The titration protocol begins at 0.6mg subcutaneously once daily for week 1, increasing by 0.6mg weekly increments: 1.2mg (week 2), 1.8mg (week 3), 2.4mg (week 4), and the maintenance dose of 3.0mg daily from week 5 onwards [2]. This gradual escalation allows the gastrointestinal system to adapt to liraglutide's effects on gastric motility and reduces the incidence of nausea, vomiting, and diarrhoea.

Each Saxenda pen contains 18mg of liraglutide (3ml solution), providing 6 days of treatment at the 3.0mg maintenance dose or longer duration during the titration phase. Patients self-administer the injection subcutaneously into the abdomen, thigh, or upper arm at any time of day, with or without meals, maintaining consistency in timing. If you miss a dose within 12 hours of the scheduled time, administer it as soon as possible; if more than 12 hours have elapsed, skip the missed dose and resume the next day [2]. Treatment discontinuation is recommended if patients fail to achieve ≥5% weight loss after 12 weeks at the 3.0mg maintenance dose, as continued therapy is unlikely to yield clinically meaningful benefit.

Pricing and Discounts to Purchase Saxenda UK at Cured Pharmacy

At Cured Pharmacy, you can purchase Saxenda UK from £48.00 per pen, representing competitive UK pricing for this prescription weight-loss treatment. New patients Save £20 on their first order using code Weightlossnew, reducing the initial price to £48.00 and making Saxenda accessible for those beginning their weight management journey. Our transparent pricing model displays all costs upfront before the consultation, with no hidden fees or subscription obligations, and includes free UK delivery on all orders.

The cost-effectiveness of purchasing Saxenda UK improves with treatment adherence and successful weight outcomes. In the SCALE Obesity and Prediabetes trial, participants maintained an average weight loss of 6.2% at 3 years versus 1.9% placebo, demonstrating sustained efficacy with continued use [1]. Cured Pharmacy sources all Saxenda directly from UK-licensed wholesalers, guaranteeing genuine Novo Nordisk product with full cold-chain integrity and batch traceability. Our GPhC-registered pharmacy (9012511) operates under stringent quality assurance protocols, ensuring every pen dispensed meets MHRA standards for safety and efficacy.

Transparent Pricing Before Consultation

Unlike some online providers, when you purchase Saxenda UK through Cured Pharmacy, you see the exact price before completing your clinical assessment. This transparency allows informed decision-making and budget planning, particularly for patients considering long-term weight management therapy. The free online consultation with our UK-registered prescribers takes under 3 minutes, with most assessments reviewed and approved within hours for same-day dispatch.

Expected Outcomes When You Purchase Saxenda UK for Weight Loss

Clinical trial data provide realistic expectations for patients who purchase Saxenda UK and adhere to the prescribed regimen. The SCALE Obesity and Prediabetes trial enrolled 3,731 participants without type 2 diabetes, randomising them to liraglutide 3.0mg or placebo alongside lifestyle intervention. At 56 weeks, the liraglutide group lost an average of 8.4±7.3 kg (8.0% of initial body weight) compared to 2.8±6.5 kg (2.6%) with placebo [1]. Importantly, 63.2% of liraglutide-treated participants achieved ≥5% weight loss (primary endpoint) versus 27.1% placebo, and 33.1% achieved ≥10% weight loss versus 10.6% placebo.

In patients with type 2 diabetes (SCALE Diabetes trial), liraglutide 3.0mg produced mean weight loss of 6.0% versus 2.0% placebo at 56 weeks, with concurrent improvements in HbA1c of -1.3% versus -0.4% [4]. These outcomes demonstrate that when you purchase Saxenda UK and use it as directed with dietary modification and increased physical activity, clinically significant weight reduction is achievable for the majority of suitable patients. However, individual responses vary based on baseline BMI, adherence, lifestyle factors, and metabolic characteristics, and no specific outcome can be guaranteed.

Safety Considerations When You Purchase Saxenda UK

When you purchase Saxenda UK, understanding the safety profile ensures informed consent and appropriate monitoring. The most common adverse effects are gastrointestinal: nausea (39.3% vs 13.8% placebo), diarrhoea (20.9% vs 9.9%), constipation (19.4% vs 8.5%), and vomiting (15.7% vs 3.9%) in the SCALE trials [1]. These symptoms typically occur during dose escalation, are mild to moderate in severity, and resolve within days to weeks as tolerance develops. Slower titration or temporary dose reduction can mitigate persistent gastrointestinal intolerance.

Serious adverse events requiring clinical awareness include acute pancreatitis (0.3% incidence in trials), gallbladder disorders including cholelithiasis, and hypoglycaemia when used concomitantly with insulin or sulphonylureas [2]. Liraglutide carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though causality in humans has not been established; nonetheless, it remains contraindicated in patients with personal or family history of MTC or MEN 2 [3]. At Cured Pharmacy, our prescribers provide comprehensive safety counselling during the consultation, and patients are advised to report persistent abdominal pain, visual changes, or signs of thyroid nodules immediately.

Monitoring and Follow-Up After Purchase

After you purchase Saxenda UK and commence treatment, ongoing monitoring optimises safety and efficacy. We recommend weighing yourself weekly at the same time of day, tracking progress toward the 5% weight loss threshold at 12 weeks. Blood pressure and heart rate should be monitored periodically, particularly in patients with pre-existing cardiovascular conditions. Our clinical team remains available for medication reviews, dose adjustments, and management of any adverse effects throughout your treatment journey.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 13 August 2026]
2. Novo Nordisk. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2020). Liraglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA664]. [accessed 13 August 2026]
4. Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., ... & DeFronzo, R. A. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA, 314(7), 687-699. [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.